Tilray medical receives italy's first authorization from the ministry of health to distribute medical cannabis flower for therapeutic use

Savona, italy, june 24, 2025 (globe newswire) -- tilray medical (“tilray”), a division of tilray brands, inc. (nasdaq: tlry and tsx: tlry) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a significant milestone in its european expansion with the introduction of three new medical cannabis flower varieties in italy. through its wholly-owned subsidiary, fl group, tilray has become the first company in italy to receive official authorization from the ministero della salute (italian ministry of health) to import and distribute proprietary tilray medical-branded medical cannabis flower for therapeutic use.
TLRY Ratings Summary
TLRY Quant Ranking